Executive Committee: HBM Healthcare Investments AG

Manager
Positions heldSince
Andreas Wicki

Andreas Wicki

66 year

Chief Executive Officer 19/02/2012
Erwin Troxler

Erwin Troxler

56 year

Director of Finance/CFO 31/10/2011
Benedikt Suter

Benedikt Suter

62 year

Corporate Secretary -
Nina Good

Nina Good

Compliance Officer -
Thomas Heimann

Thomas Heimann

Chief Operating Officer -

Composition of the Board of Directors: HBM Healthcare Investments AG

Director
CommitteesSince
Hans-Peter Hasler

Hans-Peter Hasler

70 year

Audit Committee 28/02/2021
Compensation Committee
Governance Committee
Nominating Committee 12/12/2017
Nominating Committee Chair 28/02/2021
Governance Committee Chair 28/02/2021
Elaine Jones

Elaine Jones

71 year

Audit Committee 30/11/2015
Governance Committee Chair 30/11/2015
Nominating Committee Chair 30/11/2015
Compensation Committee
Governance Committee 30/04/2019
Nominating Committee 30/04/2019
Rudolf Lanz

Rudolf Lanz

76 year

Audit Committee 19/02/2012
Nominating Committee 19/02/2012
Stella Xu

Stella Xu

55 year

Director/Board Member 31/05/2020
Mario Giuliani

Mario Giuliani

54 year

Director/Board Member 31/12/2011

Former Officers and Directors: HBM Healthcare Investments AG

Insider
Positions held
SinceUntil
Heinz Riesenhuber
Heinz Riesenhuber
Director/Board Member 31/12/2000 17/06/2021
Eduard Enrico Holdener
Eduard Enrico Holdener
Director/Board Member 31/12/2007 17/06/2021
Robert Alexander Ingram
Robert Alexander Ingram
Director/Board Member 31/12/2005 17/06/2021
Erich Maximilian Platzer
Erich Maximilian Platzer
Founder 31/12/2000 -
Gary T. Shearman
Gary T. Shearman
Corporate Officer/Principal - -
Daniel Richner
Daniel Richner
Corporate Officer/Principal - -

Age distribution of managers

Parity Men Women

Male10
Female1

Of which Executive Committee

Male4
Female1

Of which Directors

Male5
Female0
Logo HBM Healthcare Investments AG
HBM Healthcare Investments AG is a Switzerland-based venture capital company investing in emerging companies, mainly from the biotechnology and human medicine, diagnostics, as well as medical technology sectors. The Company focuses on unlisted companies, with two-thirds of assets being invested in private companies that offer high value-creation potential. As a holding company, it is involved in the acquisition, disposal and management of a diversified portfolio, as well as in financing and supporting the portfolio firms as a key partner. It focuses on companies with products either at an advanced stage of development or already available on the market. The primary investment areas are Western Europe and the United States. The Company's portfolio includes approximately 25 companies. As of March 31, 2012, the Company had six wholly owned subsidiaries, including three subsidiaries on Cayman Islands, two Barbados-based subsidiaries and a subsidiary in the United States.
Employees
700
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!